Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Clagett-Carr

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|September 1, 1985
Results of NCI-sponsored phase I trials with carboplatinB J Foster, K Clagett-Carr, B Leyland-Jones, et al.
Cancer Treatment Reports|November 1, 1986
Gallium nitrate: the second metal with clinical activityB J Foster, K Clagett-Carr, D Hoth, et al.
Cancer Treatment Reports|March 1, 1986
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamineB J Foster, K Clagett-Carr, D Hoth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizerK Clagett-Carr, G Sarosy, J Plowman, et al.
Cancer Treatment Reports|August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?B J Foster, K Clagett-Carr, S Marsoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIPB J Foster, B J Harding, M K Wolpert-DeFilippes, et al.
Investigational New Drugs|January 1, 1985
Echinomycin: the first bifunctional intercalating agent in clinical trialsB J Foster, K Clagett-Carr, D D Shoemaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Patient treatment on a compassionate basis: documentation of high adverse drug reaction rateB Leyland-Jones, B R Davies, K Clagett-Carr, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|September 1, 1985
Results of NCI-sponsored phase I trials with carboplatinB J Foster, K Clagett-Carr, B Leyland-Jones, et al.
Cancer Treatment Reports|November 1, 1986
Gallium nitrate: the second metal with clinical activityB J Foster, K Clagett-Carr, D Hoth, et al.
Cancer Treatment Reports|March 1, 1986
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamineB J Foster, K Clagett-Carr, D Hoth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizerK Clagett-Carr, G Sarosy, J Plowman, et al.
Cancer Treatment Reports|August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?B J Foster, K Clagett-Carr, S Marsoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIPB J Foster, B J Harding, M K Wolpert-DeFilippes, et al.
Investigational New Drugs|January 1, 1985
Echinomycin: the first bifunctional intercalating agent in clinical trialsB J Foster, K Clagett-Carr, D D Shoemaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Patient treatment on a compassionate basis: documentation of high adverse drug reaction rateB Leyland-Jones, B R Davies, K Clagett-Carr, et al.
Pageof 1